Search Clinical Pathways
Inflammatory Bowel Disease with Iron Deficiency and Anemia Clinical Pathway — All Settings
Clinical Care Pathway for screening, management and follow up of iron deficiency and anemia among patients with Inflammatory Bowel Disease.
Preparation for Anesthesia/Sedation Clinical Pathway – Inpatient and Emergency Department
This pathway guides care of patients in the Emergency Department and inpatient units coming to the General Operating Rooms and radiologic procedures under Anesthesia/sedation.
Acute Pulmonary Embolism Clinical Pathway — Emergency Department, ICU and Inpatient
This pathway will guide the evaluation and treatment of a pediatric patient with a suspected acute pulmonary embolism/embolus.
Tumor Lysis Syndrome Clinical Pathway — Inpatient, ICU
This pathway is to be used for oncology patients with a new diagnosis/new relapse of a hematological malignancy or bulky solid tumor with presence of high risk criteria.
Screening Infants and Children at Risk for Fractures Clinical Pathway — Inpatient
This pathway guides clinicians in laboratory studies and appropriate consultation to Bone Health team as needed, with a goal to prevent any fractures from occurring while children are in the hospital.
Sickle Cell and Acute Chest Syndrome Clinical Pathway — Inpatient
Treatment for the hospitalized Sickle Cell patient with Acute Chest Syndrome.
Aplastic Anemia Clinical Pathway — All Settings
This pathway is used to evaluate the treatment of the child with suspected acquired aplastic anemia.
Acute Chemotherapy Induced Nausea and Vomiting (CINV) Clinical Pathway — Inpatient and Outpatient Specialty
The Prevention of Acute Chemotherapy-Induced Nausea and Vomiting Clinical Pathway provides guidance for selecting anti-emetics and non-pharmacologic therapies for patients receiving chemotherapy.
Beckwith-Wiedemann Syndrome Clinical Pathway — N/IICU
The Beckwith-Wiedemann Syndrome (BWS) Clinical Pathway provides guidance of care for neonates/infants born at the CHOP SDU or referred from outside institutions for further evaluation and treatment with overgrowth features such as macroglossia, hyperinsulinism, omphalocele and/or a constellation of findings suspicious for BWS.